AVBP EPS Estimates
ArriVent BioPharma, Inc. Common Stock
$16.20
+$0.11(+0.68%)
33
Overall
60
Value
18
Tech
21
Quality
Market Cap
$798.79M
Volume
1.59M
52W Range
$11.36 - $35.83
Target Price
$23.40
AVBP EPS estimates: the consensus estimate for ArriVent BioPharma, Inc. Common Stock's current fiscal year is -$4.05 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AVBP EPS Estimates
- EPS estimate, current quarter
- $-1.06
- EPS estimate, next quarter
- $-1.05
- EPS estimate, current year
- $-4.05
- EPS estimate, next year
- $-3.82
- EPS growth, 3-year
- -1100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-4.32 |
| 2024 | $-2.56 |
| 2022 | $-0.03 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVBP | $16.20 | +0.7% | 1.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ArriVent BioPharma, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW